Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Apr 13;24(13):1506–1514. doi: 10.1089/scd.2015.0022

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright 2015, Mary Ann Liebert, Inc.

PMC Copyright notice

FIG. 4. — Analysis of drug resistance and in vitro differentiation. (A) The percentage of CD34+ cells on mouse embryonic fibroblasts feeder cell culture. (B) The percentage of CD34+ cells at day 3 on ECM after being moved from feeder cell culture. (C) The percentage of CD34+ cells at day 14 on ECM culture after being moved from feeder cell culture. (D) The percentage of CD34+ cells at day 14 on ECM culture with treatment by cisplatin at 2 μg/mL from day 7 after being moved from feeder cell culture. (E) Expression of liver genes [albumin (ALB), AFP, CK19, and CK7], liver cancer markers (CD133, EpCAM, CD44, and CD90), as well as CD31 and CD34 was evaluated by qPCR at days 4, 9, and 13 after the differentiation of cloned CD34+ LCSC and compared to undifferentiated cloned CD34+ LCSC (CD34+). All values are mean±SEM from three independent experiments. *P<0.05; **P<0.01.